Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA

類似資料

• Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States
  著者:: Raedler, Lisa A.
  出版事項: (2016)
• FDA Advisory Committee Approval of First Biosimilar Leaves Questions Unanswered: Sandoz’s Filgrastim Faces Naming and Court Hurdles
  著者:: Barlas, Stephen
  出版事項: (2015)
• FDA and EMA Biosimilar Approvals
  著者:: Jung, Emily H., 等
  出版事項: (2019)
• Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III Studies
  著者:: Harbeck, Nadia, 等
  出版事項: (2018)
• The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
  著者:: Gherghescu, Ioana, 等
  出版事項: (2020)